137 related articles for article (PubMed ID: 28587987)
1. Sphingosine kinase 1 (SK1) allosteric inhibitors that target the dimerization site.
Bayraktar O; Ozkirimli E; Ulgen K
Comput Biol Chem; 2017 Aug; 69():64-76. PubMed ID: 28587987
[TBL] [Abstract][Full Text] [Related]
2. In Silico Identification of Novel Orthosteric Inhibitors of Sphingosine Kinase 1 (SK1).
Bayraktar O; Ozkirimli E; Ulgen KO
Curr Protein Pept Sci; 2018; 19(5):430-444. PubMed ID: 27829348
[TBL] [Abstract][Full Text] [Related]
3. FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells.
Lim KG; Tonelli F; Li Z; Lu X; Bittman R; Pyne S; Pyne NJ
J Biol Chem; 2011 May; 286(21):18633-40. PubMed ID: 21464128
[TBL] [Abstract][Full Text] [Related]
4. Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors.
Alshaker H; Srivats S; Monteil D; Wang Q; Low CMR; Pchejetski D
Breast Cancer Res Treat; 2018 Nov; 172(1):33-43. PubMed ID: 30043096
[TBL] [Abstract][Full Text] [Related]
5. Assessing the ligand selectivity of sphingosine kinases using molecular dynamics and MM-PBSA binding free energy calculations.
Fang L; Wang X; Xi M; Liu T; Yin D
Mol Biosyst; 2016 Apr; 12(4):1174-82. PubMed ID: 26927311
[TBL] [Abstract][Full Text] [Related]
6. Characterization of isoenzyme-selective inhibitors of human sphingosine kinases.
Gao P; Peterson YK; Smith RA; Smith CD
PLoS One; 2012; 7(9):e44543. PubMed ID: 22970244
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine kinase 1 as an anticancer therapeutic target.
Gao Y; Gao F; Chen K; Tian ML; Zhao DL
Drug Des Devel Ther; 2015; 9():3239-45. PubMed ID: 26150697
[TBL] [Abstract][Full Text] [Related]
8. Structure-function analysis of lipid substrates and inhibitors of sphingosine kinases.
Adams DR; Pyne S; Pyne NJ
Cell Signal; 2020 Dec; 76():109806. PubMed ID: 33035646
[TBL] [Abstract][Full Text] [Related]
9. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.
Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A
J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193
[TBL] [Abstract][Full Text] [Related]
10. Topographical Mapping of Isoform-Selectivity Determinants for J-Channel-Binding Inhibitors of Sphingosine Kinases 1 and 2.
Adams DR; Tawati S; Berretta G; Rivas PL; Baiget J; Jiang Z; Alsfouk A; Mackay SP; Pyne NJ; Pyne S
J Med Chem; 2019 Apr; 62(7):3658-3676. PubMed ID: 30889352
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel sphingosine kinase 1 inhibitors.
Xiang Y; Asmussen G; Booker M; Hirth B; Kane JL; Liao J; Noson KD; Yee C
Bioorg Med Chem Lett; 2009 Nov; 19(21):6119-21. PubMed ID: 19800228
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships and molecular modeling of sphingosine kinase inhibitors.
Baek DJ; MacRitchie N; Anthony NG; Mackay SP; Pyne S; Pyne NJ; Bittman R
J Med Chem; 2013 Nov; 56(22):9310-27. PubMed ID: 24164513
[TBL] [Abstract][Full Text] [Related]
13. Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy.
Yaghobian D; Don AS; Yaghobian S; Chen X; Pollock CA; Saad S
Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):56-66. PubMed ID: 26414003
[TBL] [Abstract][Full Text] [Related]
14. A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties.
Pitman MR; Powell JA; Coolen C; Moretti PA; Zebol JR; Pham DH; Finnie JW; Don AS; Ebert LM; Bonder CS; Gliddon BL; Pitson SM
Oncotarget; 2015 Mar; 6(9):7065-83. PubMed ID: 25788259
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Akt1 allosteric site to identify novel scaffolds through virtual screening.
Yilmaz OG; Olmez EO; Ulgen KO
Comput Biol Chem; 2014 Feb; 48():1-13. PubMed ID: 24291487
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of (S)-FTY720 vinylphosphonate analogues and evaluation of their potential as sphingosine kinase 1 inhibitors and activators.
Liu Z; MacRitchie N; Pyne S; Pyne NJ; Bittman R
Bioorg Med Chem; 2013 May; 21(9):2503-10. PubMed ID: 23541833
[TBL] [Abstract][Full Text] [Related]
17. A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma.
Salama MF; Carroll B; Adada M; Pulkoski-Gross M; Hannun YA; Obeid LM
FASEB J; 2015 Jul; 29(7):2803-13. PubMed ID: 25805832
[TBL] [Abstract][Full Text] [Related]
18. De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.
Berdyshev EV; Gorshkova IA; Usatyuk P; Zhao Y; Saatian B; Hubbard W; Natarajan V
Cell Signal; 2006 Oct; 18(10):1779-92. PubMed ID: 16529909
[TBL] [Abstract][Full Text] [Related]
19. Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.
Pyne NJ; McNaughton M; Boomkamp S; MacRitchie N; Evangelisti C; Martelli AM; Jiang HR; Ubhi S; Pyne S
Adv Biol Regul; 2016 Jan; 60():151-159. PubMed ID: 26429117
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of targeting SK1 in human cancers.
Alshaker H; Sauer L; Monteil D; Ottaviani S; Srivats S; Böhler T; Pchejetski D
Adv Cancer Res; 2013; 117():143-200. PubMed ID: 23290780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
